Medical device company Boston Scientific to shed 50 jobs at its Galway facility as part of its 2011 restructuring plan.
The cuts are tied to a 2011 global restructuring plan for the medical device company, according to a BSX spokesman.
Boston Scientific employs 2,500 at the Galway facility, which is the largest of its 3 manufacturing facilities in Ireland. Overall, the medical device company employs about 4,500 in the Emerald Isle.
In a statement sent to MassDevice, company officials said the job cuts were made to "align its workforce and operations with the company’s global initiative to operate more cost effectively. The company has designated Galway to be its global Centre of Excellence for Drug Eluting Stent (DES) manufacturing. This means DES manufacturing will be consolidated there and certain non-drug eluting stents will be transferred to other Boston Scientific manufacturing facilities."
Officials added that " Boston Scientific will offer affected Galway employees a comprehensive support programme. Boston Scientific remains committed to supporting its employees through this transition."
Boston Scientific announced in July 2011, that it was looking to cut up to 1,400 jobs in a restructuring program aimed at saving $225-$275 million annually by 2013. The company recorded about $116 million in restructuring and divestiture-related charges during the 2nd quarter.
Here's a look at some of the top funding stories for medical device companies this week.
FDA officials warn against the use of "laparoscopic power morcellation" for the removal of uterine...
Bio-artificial liver maker Vital Therapies takes its IPO even lower, now planning to open at $12 per...
California surgical devices maker Cardica details a public offering of common and preferred stock...